Építés alatt – nem éles oldal
Belépés
Visszavonva2. fázis

Oxytocin on Approach Bias and Craving

A legfontosabb adatok

Ki végzi
Jennifer Mitchell
Hol
Berkeley (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Visszavonva
Fázis
2. fázis
Kezdés
2023. nov. 1.
Befejezés
2024. ápr. 20.
A vizsgálat típusa
Beavatkozással járó, 2 csoport
A vizsgált kezelések
  • Oxytocin
  • Placebo
A regiszteradat frissítve
2022. június 6.
Miért állt le
COVID made study visits impossible during the funding period.

Ki vehet részt

Életkor
21 év – 40 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 29 feltétel megnézéseKevesebb

Ki vehet részt

  • Healthy volunteers who are 21-40 years of age
  • If female, 10 or more alcoholic drinks must be consumed weekly
  • If male, 14 or more alcoholic drinks must be consumed weekly
  • Meets DSM-V criteria for Alcohol Use Disorder (AUD)
  • Score 8 or greater on the Alcohol Use Disorders Identification Test (AUDIT)
  • If female, must be non-lactating, not pregnant, and using a reliable contraception method (i.e. abstinence, intrauterine device [IUD], hormonal birth control, or barrier method)
  • Native English speaker
  • Right handed
  • High school graduate or equivalent
  • Able and willing to provide an informed consent
  • Able to understand and follow the instructions of the investigator

Ki nem vehet részt

  • Positive urine drug screen (except marijuana)
  • Using cocaine, stimulants (other than nicotine and caffeine), amphetamines, hallucinogens, ecstasy, opiates, sedatives, pain pills, sleeping pills, or other psychoactive drugs within 2 weeks of the start of the study (except marijuana)
  • Current enrollment in an alcohol, or other drug treatment program or current legal problems relating to alcohol, or other drug use
  • Has received an investigational drug within 30 days of Screening Visit
  • History of major alcohol related complications within the preceding 2 years (liver failure/cirrhosis, pancreatitis, esophageal varices, etc.)
  • Has a history of atrophic rhinitis, recurrent nose bleeds, cranial surgical procedures, hypophysectomy, chronic congestion, or sinus problems
  • Has a history of cardiac arrhythmia
  • Clinically significant medical or psychiatric illness requiring treatment as determined by screening blood tests, medical history, and/or physical exam performed or reviewed by the study physician
  • Has a neurological dysfunction or psychiatric disorder (confirm with study physician)
  • Has a history of brain trauma (confirm with study physician)
  • Has an allergy or intolerance to oxytocin
  • Has a history of claustrophobia
  • SGPT/ALT or SGOT/AST values greater than 2x upper limit of normal
  • Marijuana use more than 3 times/week
  • Currently trying to quit alcohol use
  • Severely low blood (< 90/50) pressure or uncontrolled high blood pressure (>160/100)
  • BAC level > 0.00% at the beginning of screening visit (within margin of error of detection)
  • Has any MRI scanning contraindications

Helyszínek itt: Egyesült Államok

  • University of California, San FranciscoBerkeley, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

This will be a laboratory-based investigation of the behavioral and neural effects of intranasal oxytocin on craving for alcohol and approach bias in moderate to heavy alcohol using subjects. This study uses a within-subject, randomized, placebo-controlled, counterbalanced, crossover design to compare the effects oxytocin and placebo. In this way, all subjects will be scanned twice; once following oxytocin administration and once following placebo administration, and will complete a series of behavioral tasks (both in and out of the scanner) at both visits.

A vizsgálat 2 csoportja

  • Oxytocin FirstA vizsgált kezelés

    Subjects will receive oxytocin prior to their first scanning session, and placebo prior to their second scanning session.

    Kezelés: Oxytocin és Placebo

  • Placebo FirstA vizsgált kezelés

    Subjects will receive placebo prior to their first scanning session, and oxytocin prior to their second scanning session.

    Kezelés: Oxytocin és Placebo

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
The Effects of Intranasal Oxytocin on Approach Bias and Craving in Moderate to Heavy Alcohol Drinkers
A regiszteradat frissítve
2022. június 6.